IBI Istituto Biochimico Italiano G. Lorenzini S.p.A. is an Italian pharmaceutical company with global reach and 99 years of experience. It has a consolidated leadership in sterile penicillin market and expertise in aseptic filling for injectable drug products aimed for different therapeutic areas.
We aim to expand our hospital and retail portfolio abroad and look for in-licencing opportunities.
We are present in hospital segment in Italy, Germany and UK with affiliates where Ibisqus Hospital Line is dedicated to pharmacists and purchasing stakeholders, while we commercialize our retail products in Italy through a distribution partner. Worldwide we commercialize our hospital and retail products through partners in the other markets in EU, USA, Australia, ASIA.
The major part of IBI portfolio comes from direct production (Plant based in Italy) of injectable products, oral forms, drops and others products. The production is under the cGMP norms and is certified by the most demanding Health Authorities: FDA, AIFA, EDQM, TGA.
CIR (Crédit d'Impôt Recherche) accreditation was achieved from the French Ministry of Research (Ministère de l'Enseignement Supérieur et de la Recherche) for 2016, 2017, 2018.